© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
October 21, 2008
Rates of death and myocardial infarction were assessed for a national sample of acute coronary syndrome patients after stopping clopidogrel. In the first 90 days after stopping treatment, patients experienced a nearly twofold increased risk of adverse events compared with subsequent follow-up intervals for patients
treated medically without stents and for patients treated with coronary stents. This suggests a possible clopidogrel rebound effect, but additional studies are needed to support this hypothesis and to identify strategies to reduce early
events after clopidogrel cessation.
Eyes with nAMD Treated with Ranibizumab Maintained Visual Acuity at SRF Resolution
Dietary Eliminations May Not Significantly Benefit Pediatric Eczema
Antibiotics to Treat Upper Respiratory Infections Increase Risk of C Difficile Infections